| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |